Ceribell Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ceribell Inc 's inventory turnover ratio, the ratio that measures Ceribell Inc 's ability to manage its supply chain, sequentially decreased to 1.66 in the second quarter 2026, but it does not raise any concerns as Ceribell Inc continue to execute well, and the inventory turnover ratio remains above the average. Ceribell Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 220 days, from 217 days, in the Mar 31 2026 quarter.

Within Healthcare sector 237 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1215 in the first quarter 2026, to 1635.

CBLL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ceribell Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBLL Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	12.28 %	5.33 %	5.06 %	-12.82 %	2.25 %
Y / Y Cost of Sales Growth	7.95 %	50 %	74.22 %	0 %	-7.24 %
Inventory Turnover Ratio (TTM)	1.66	1.68	1.55	1.3	1.26
CBLL's Total Ranking	# 1635	# 1215	# 1215	# 984	# 1385
Average inventory processing period	220	217	236	281	290
Seq. Inventory Growth	-2.39 %	-5.3 %	20.98 %	0.4 %	-8.44 %
Seq. Cost of Sales Growth	-28.03 %	-25 %	100 %	0 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 107
Healthcare Sector	# 238
Overall Market	# 1635

Inventory Turnover Ratio Statistics
High	Average	Low
1.68	1.45	1.26
(Mar 31 2026)		(Jun 30 2025)

CBLL Company Profile >> Back to CBLL Efficiency Comparisons >> Compare CBLL Inventory Turnover Ratio to its Competitors

Financial Statements
Ceribell Inc 's Inventories	$ 7 Millions	Visit CBLL's Balance sheet
Ceribell Inc 's Cost of Revenues TTM	$ 11 Millions	Visit CBLL's Income Statement
What are CBLL's Sales?		Visit CBLL's Sales by Segment

Other Inventory Turnover Ratios
Ceribell Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CBLL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CBLL's Competitors
Inventory Turnover Ratio for CBLL's Suppliers
Inventory Turnover Ratio for CBLL's Customers

You may also want to know
CBLL's Sales Growth Rates	CBLL's Pe Price to earnings ratio	CBLL's Receivables Turnover Ratio	CBLL's Stock Quote
CBLL's Net Income Growth Rates	CBLL's Ps Price to Sales ratio	CBLL's Sales per Employee	CBLL's Asset Turnover Ratio
CBLL's Net Margin	CBLL's Pb Price to Book ratio	CBLL's Financial Strength Ratios	CBLL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions

Date modified: 2026-08-13T07:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.